FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2150981177> ?p ?o ?g. }

• W2150981177 endingPage "1417" @default.
• W2150981177 startingPage "1407" @default.
• W2150981177 abstract "Advax is a polysaccharide-based adjuvant that potently stimulates vaccine immunogenicity without the increased reactogenicity seen with other adjuvants. This study investigated the immunogenicity of a novel Advax-adjuvanted Vero cell culture candidate vaccine against Japanese encephalitis virus (JEV) in mice and horses. The results showed that, in mice, a two-immunization, low-dose (50 ng JEV antigen) regimen with adjuvanted vaccine produced solid neutralizing immunity comparable to that elicited with live ChimeriVax-JE immunization and superior to that elicited with tenfold higher doses of a traditional non-adjuvanted JEV vaccine (JE-VAX; Biken Institute) or a newly approved alum-adjuvanted vaccine (Jespect; Novartis). Mice vaccinated with the Advax-adjuvanted, but not the unadjuvanted vaccine, were protected against live JEV challenge. Equine immunizations against JEV with Advax-formulated vaccine similarly showed enhanced vaccine immunogenicity, confirming that the adjuvant effects of Advax are not restricted to rodent models. Advax-adjuvanted JEV vaccine elicited a balanced T-helper 1 (Th1)/Th2 immune response against JEV with protective levels of cross-neutralizing antibody against other viruses belonging to the JEV serocomplex, including Murray Valley encephalitis virus (MVEV). The adjuvanted JEV vaccine was well tolerated with minimal reactogenicity and no systemic toxicity in immunized animals. The cessation of manufacture of traditional mouse brain-derived unadjuvanted JEV vaccine in Japan has resulted in a JEV vaccine shortage internationally. There is also an ongoing lack of human vaccines against other JEV serocomplex flaviviruses, such as MVEV, making this adjuvanted, cell culture-grown JEV vaccine a promising candidate to address both needs with one vaccine." @default.
• W2150981177 created "2016-06-24" @default.
• W2150981177 creator A5015718792 @default.
• W2150981177 creator A5042392287 @default.
• W2150981177 creator A5068925184 @default.
• W2150981177 creator A5069199174 @default.
• W2150981177 creator A5072894345 @default.
• W2150981177 creator A5083440772 @default.
• W2150981177 creator A5086536923 @default.
• W2150981177 date "2010-02-03" @default.
• W2150981177 modified "2023-10-12" @default.
• W2150981177 title "An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses" @default.
• W2150981177 cites W1513149807 @default.
• W2150981177 cites W1550223075 @default.
• W2150981177 cites W1654814305 @default.
• W2150981177 cites W1977011552 @default.
• W2150981177 cites W1982895831 @default.
• W2150981177 cites W1994617882 @default.
• W2150981177 cites W2010459278 @default.
• W2150981177 cites W2014571326 @default.
• W2150981177 cites W2026972461 @default.
• W2150981177 cites W2027897465 @default.
• W2150981177 cites W2045151225 @default.
• W2150981177 cites W2067749638 @default.
• W2150981177 cites W2072422045 @default.
• W2150981177 cites W2073742945 @default.
• W2150981177 cites W2074326156 @default.
• W2150981177 cites W2074553605 @default.
• W2150981177 cites W2077196435 @default.
• W2150981177 cites W2078998316 @default.
• W2150981177 cites W2083589191 @default.
• W2150981177 cites W2095950478 @default.
• W2150981177 cites W2110990893 @default.
• W2150981177 cites W2118732753 @default.
• W2150981177 cites W2118911422 @default.
• W2150981177 cites W2132290947 @default.
• W2150981177 cites W2139605631 @default.
• W2150981177 cites W2140048277 @default.
• W2150981177 cites W2140205268 @default.
• W2150981177 cites W2141845319 @default.
• W2150981177 cites W2143641667 @default.
• W2150981177 cites W2145181386 @default.
• W2150981177 cites W2158053412 @default.
• W2150981177 cites W2164294248 @default.
• W2150981177 cites W2167490505 @default.
• W2150981177 cites W2181816912 @default.
• W2150981177 cites W2317968120 @default.
• W2150981177 cites W2323126684 @default.
• W2150981177 cites W2398742800 @default.
• W2150981177 cites W4241325400 @default.
• W2150981177 cites W62662629 @default.
• W2150981177 doi "https://doi.org/10.1099/vir.0.019190-0" @default.
• W2150981177 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2888167" @default.
• W2150981177 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20130134" @default.
• W2150981177 hasPublicationYear "2010" @default.
• W2150981177 type Work @default.
• W2150981177 sameAs 2150981177 @default.
• W2150981177 citedByCount "92" @default.
• W2150981177 countsByYear W21509811772012 @default.
• W2150981177 countsByYear W21509811772013 @default.
• W2150981177 countsByYear W21509811772014 @default.
• W2150981177 countsByYear W21509811772015 @default.
• W2150981177 countsByYear W21509811772016 @default.
• W2150981177 countsByYear W21509811772017 @default.
• W2150981177 countsByYear W21509811772018 @default.
• W2150981177 countsByYear W21509811772019 @default.
• W2150981177 countsByYear W21509811772020 @default.
• W2150981177 countsByYear W21509811772021 @default.
• W2150981177 countsByYear W21509811772022 @default.
• W2150981177 countsByYear W21509811772023 @default.
• W2150981177 crossrefType "journal-article" @default.
• W2150981177 hasAuthorship W2150981177A5015718792 @default.
• W2150981177 hasAuthorship W2150981177A5042392287 @default.
• W2150981177 hasAuthorship W2150981177A5068925184 @default.
• W2150981177 hasAuthorship W2150981177A5069199174 @default.
• W2150981177 hasAuthorship W2150981177A5072894345 @default.
• W2150981177 hasAuthorship W2150981177A5083440772 @default.
• W2150981177 hasAuthorship W2150981177A5086536923 @default.
• W2150981177 hasBestOaLocation W21509811771 @default.
• W2150981177 hasConcept C159047783 @default.
• W2150981177 hasConcept C159654299 @default.
• W2150981177 hasConcept C203014093 @default.
• W2150981177 hasConcept C2522874641 @default.
• W2150981177 hasConcept C2777704310 @default.
• W2150981177 hasConcept C2777863537 @default.
• W2150981177 hasConcept C2778540732 @default.
• W2150981177 hasConcept C2779141303 @default.
• W2150981177 hasConcept C2779261636 @default.
• W2150981177 hasConcept C2779308166 @default.
• W2150981177 hasConcept C2779635636 @default.
• W2150981177 hasConcept C2780801004 @default.
• W2150981177 hasConcept C2780868878 @default.
• W2150981177 hasConcept C71924100 @default.
• W2150981177 hasConcept C83455156 @default.
• W2150981177 hasConcept C86803240 @default.
• W2150981177 hasConceptScore W2150981177C159047783 @default.
• W2150981177 hasConceptScore W2150981177C159654299 @default.
• W2150981177 hasConceptScore W2150981177C203014093 @default.

• next